James F. Ewing, PhD, is a partner and IP lawyer with Foley & Lardner. He primarily advises pharmaceutical, biotechnology, and nutraceutical clients, including companies engaged in drug discovery to develop and produce peptide and small molecule therapeutics, and encompassing such technologies as computationally assisted drug design, immunology and vaccine technologies, stem cell technologies, neurobiology, drug delivery, gene therapy technologies, nanobiology technologies and biomedical devices. Ewing has more than 15 years of experience as a research biochemist in academic medical universities and at drug discovery companies in the development of new cardiovascular, reproductive, gastrointestinal and central nervous system therapeutics, as well as antibiotics.